Background: Mastocytosis is a disorder that can be subdivided into two forms: cutaneous and systemic. Patients with cutaneous mastocytosis only may suffer from cosmetic problems. Topical steroid application has been shown to be effective in cases of limited skin lesions. Methods: A case-controlled pilot study was conducted during a 6-weeks treatment using diluted 25% fluticasone propionate 0.05% cream under wet-wrap occlusion in 5 adults and 6 children. Improvement was measured up to the 24th week after treatment using the SCORMA Index. Results: The results of this pilot study showed a partial but clear cosmetic improvement in 9 of the 11 patients. The mean SCORMA Index decreased after treatment from 38 to 26. Conclusion: 25% dilution of fluticasone propionate 0.05% cream under wet-wrap occlusion is an alternative treatment modality for alleviating the symptoms of cutaneous mastocytosis, but the improvement may be moderate and fall short of the patient's expectations. Copyright

Fluticasone propionate 25% diluted, Mastocytosis, Wet-wrap
dx.doi.org/10.1159/000100885, hdl.handle.net/1765/36678
Dermatology: international journal for clinical and investigative dermatology
Erasmus MC: University Medical Center Rotterdam

Heide, R, de Waard-van der Spek, F.B, den Hollander, J.C, Tank, B, & Oranje, A.P. (2007). Efficacy of 25% diluted fluticasone propionate 0.05% cream as wet-wrap treatment in cutaneous mastocytosis. Dermatology: international journal for clinical and investigative dermatology, 214(4), 333–335. doi:10.1159/000100885